DEK overexpression in uterine cervical cancers

Pathology International

Volumn 58, Issue 6, 2008, Pages 378-382

  Wu, Qunying ^a   Li, Zhuhu ^a   Lin, Hai ^b   Han, Longzhe ^a   Liu, Shuangping ^a   Lin, Zhenhua ^a,c  

^a YANBIAN UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervix uteri; DEK; Human; Immunohistochemistry; Papillomavirus

Indexed keywords

DEK PROTEIN; ONCOPROTEIN;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL METAPLASIA; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADENOCARCINOMA; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA, VIRAL; FEMALE; HELA CELLS; HUMANS; ONCOGENE PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 43549106140     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2008.02239.x     Document Type: Article

References (16)

1. Devany M, Kotharu NP, Matsuo H. Expression and isotopic labeling of structural domains of the human protein DEK. Protein Expr Purif 2005 40 : 244 7.
2. Johung K, Goodwin EC, DiMaio D. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence. J Virol 2007 81 : 2102 16.
3. von Lindern M, Fornerod M, van Baal S et al. The translocation (6;9), associated with specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 1992 12 : 1687 97.
4. Kappes F, Damoc C, Knippers R, Przybylski M, Pinna LA, Gruss C. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK. Mol Cell Biol 2004 24 : 6011 20.
5. Wise-Draper TM, Allen HV, Jones EE, Habash KB, Matsuo H, Wells SI. Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions. Mol Cell Biol 2006 26 : 7506 19.
6. Wise-Draper TM, Allen V, Thobe MN et al. The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7. J Virol 2005 79 : 14 309 17.
7. Larramendy ML, Niini T, Elonen E et al. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis. Haematologica 2002 87 : 569 77.
8. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: Evidence of a corepressor/coactivator exchange. Cancer Res 2007 67 : 3976 85.
9. Lin Z, Liu M, Li Z, Kim C, Lee E, Kim I. DeltaNp63 protein expression in uterine cervical and endometrial cancers. J Cancer Res Clin Oncol 2006 132 : 811 16.
10. INK4A expression in the uterine cervical intraepithelial neoplasm and invasive carcinoma in Korean women. Pathol Int 2005 55 : 491 6.
11. Sitwala KV, Adams K, Markovitz DM. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene 2002 21 : 8862 70.
12. Kappes F, Burger K, Baack M, Fackelmayer FO, Gruss C. Subcellular localization of the human proto-oncogene protein DEK. J Biol Chem 2001 276 : 26 317 23.
13. Waldmann T, Scholten I, Kappes F, Hu HG, Knippers R. The DEK protein: An abundant and ubiquitous constituent of mammalian chromatin. Gene 2004 343 : 1 9.
14. Hu HG, Scholten I, Gruss C, Knippers R. The distribution of DEK protein in mammalian chromatin. Biochem Biophys Res Commun 2007 358 : 1008 14.
15. Carro MS, Spiga FM, Quarto M et al. DEK expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle 2006 5 : 1202 7.
16. Kroes RA, Jastrow A, McLone MG et al. The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett 2000 156 : 191 8.